1. Cyberknife Treatment for Low and Intermediate Risk Prostate Cancer. (28th May 2015) Authors: Detti, B.; Bonomo, P.; Masi, L.; Doro, R.; Cipressi, S.; Iermano, C.; Bonucci, I.; Franceschini, D.; Di Cataldo, V.; Di Brina, L.; Baki, M.; Simontacchi, G.; Meattini, I.; Carini, M.; Serni, S.; Nicita, G.; Livi, L. Journal: Cancer investigation Issue: Volume 33:Number 5(2015) Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1883 Lung tumor target delineation: different segmentation strategies. (April 2019) Authors: Gasperi, C.; Borghesi, S.; Noferini, L.; Sottocornola, C.; Curion, A.S.; Zenone, F.; Pernici, P.; De Majo, R.; Nucciarelli, S.; Nanni, S.; Bertocci, S.; Gennari, P.G.; Rampini, A.; Lastrucci, L.; Iermano, C.; Tucci, E. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S1023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1447 Stereotactic radiation therapy for non-spine bone oligometastases: predictive factors of outcome. (May 2022) Authors: Borghesi, S.; Gasperi, C.; Terziani, F.; Rampini, A.; Paola, P.; De Majo, R.; Bertocci, S.; Iermano, C.; Gennari, P.G.; Losardo, P.L.; Tucci, E. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-1448 VMAT Stereotactic Ablative Radiotherapy for oligometastatic patients: role of FDG PET/CT. (May 2022) Authors: Borghesi, S.; Gasperi, C.; Terziani, F.; Curion, A.S.; Rampini, A.; Pernici, P.; Bertocci, S.; Gennari, P.G.; Iermano, C.; De Majo, R.; Losardo, P.L.; Tucci, E. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗